{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T18:29:34Z","timestamp":1766773774928,"version":"3.48.0"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:00:00Z","timestamp":1766707200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014683","name":"Region Kalmar l\u00e4n","doi-asserted-by":"publisher","award":["2798"],"award-info":[{"award-number":["2798"]}],"id":[{"id":"10.13039\/501100014683","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010805","name":"Forskningsr\u00e5det i Syd\u00f6stra Sverige","doi-asserted-by":"publisher","award":["757471"],"award-info":[{"award-number":["757471"]}],"id":[{"id":"10.13039\/100010805","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>The diagnosis of Lyme borreliosis (LB) can be challenging. The aim of this study was to investigate, describe and compare the actual use, application and documentation of LB serology in three neighbouring LB-endemic counties in Sweden. As part of this, we intended to study the concordance between laboratory reports and physicians\u2019 assessments regarding LB.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Three hundred patients sampled for LB serology in the counties of J\u00f6nk\u00f6ping, Kalmar and \u00d6sterg\u00f6tland, in 2016 were randomly selected for this study. Data was collected from the laboratory information technology systems of the departments of Clinical Microbiology in the three counties and from medical records.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Suspected Lyme neuroborreliosis (LNB) was the most common indication for LB serology, and was found in a total of 188\/300 (63%) patients: 75\/100 in J\u00f6nk\u00f6ping, 66\/100 in \u00d6sterg\u00f6tland and 47\/100 in Kalmar. Cerebrospinal fluid examination was performed on a minority of patients in whom LNB was suspected, 34\/188 (18%). LB serology was performed on sera from 15 patients with suspected erythema migrans. Sufficient information to enable an assessment of concordance between laboratory reports and medical records was available for 158\/300 (53%) patients, while 94\/158 (59%) were considered to have concordant records.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>LB serology is frequently performed on questionable indications contrary to guidelines, which limits the value and potential of the analysis. Notably, the use appears to be different in three neighbouring counties that follow the same national guidelines. Although new diagnostic technologies, may improve laboratory diagnostics in the future, there is still a need for interventions to enable a more rational use of LB serology.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0339449","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T18:25:17Z","timestamp":1766773517000},"page":"e0339449","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Deficiencies in communication between clinical microbiological laboratories and physicians may impair the diagnosis of Lyme borreliosis: A study of the use and application of serology in three neighbouring counties in Sweden"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3425-0700","authenticated-orcid":true,"given":"Marcus","family":"Johansson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Hillerdal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matilda Ljungqvist","family":"L\u00f6vmar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lena","family":"Serrander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna J.","family":"Henningsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivar","family":"Tjernberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,12,26]]},"reference":[{"issue":"1","key":"pone.0339449.ref001","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1469-0691.2010.03175.x","article-title":"Lyme borreliosis: clinical case definitions for diagnosis and management in Europe","volume":"17","author":"G Stanek","year":"2011","journal-title":"Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases"},{"issue":"9","key":"pone.0339449.ref002","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJM198908313210906","article-title":"Lyme disease","volume":"321","author":"AC Steere","year":"1989","journal-title":"N Engl J Med"},{"issue":"11","key":"pone.0339449.ref003","first-page":"897","article-title":"Review of Lyme Borreliosis in Africa-An Emerging Threat in Africa","volume":"13","author":"N Doss","year":"2024","journal-title":"Biology (Basel)"},{"issue":"2","key":"pone.0339449.ref004","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00018-19","article-title":"Laboratory diagnosis of Lyme borreliosis","volume":"34","author":"JA Branda","year":"2021","journal-title":"Clinical Microbiology Reviews"},{"issue":"1","key":"pone.0339449.ref005","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1021\/acsnano.9b08151","article-title":"Point-of-Care Serodiagnostic Test for Early-Stage Lyme Disease Using a Multiplexed Paper-Based Immunoassay and Machine Learning","volume":"14","author":"H-A Joung","year":"2020","journal-title":"ACS Nano"},{"issue":"1722","key":"pone.0339449.ref006","doi-asserted-by":"crossref","first-page":"20160117","DOI":"10.1098\/rstb.2016.0117","article-title":"Lyme disease ecology in a changing world: consensus, uncertainty and critical gaps for improving control","volume":"372","author":"AM Kilpatrick","year":"2017","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"1","key":"pone.0339449.ref007","first-page":"74","article-title":"An estimate of Lyme borreliosis incidence in Western Europe\u2020","volume":"39","author":"RA Sykes","year":"2017","journal-title":"J Public Health (Oxf)"},{"issue":"5","key":"pone.0339449.ref008","first-page":"219","article-title":"Surveillance for Lyme disease in Canada, 2009-2019","volume":"48","author":"S Gasmi","year":"2022","journal-title":"Canada communicable disease report = Relev\u00e9 des maladies transmissibles au Canada"},{"key":"pone.0339449.ref009","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000213070","article-title":"Clinical manifestations and diagnosis of lyme borreliosis","author":"F Strle","year":"2009","journal-title":"Curr Probl Dermatol"},{"issue":"3","key":"pone.0339449.ref010","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/femsre\/fux047","article-title":"Lyme borreliosis-from tick bite to diagnosis and treatment","volume":"42","author":"G Stanek","year":"2018","journal-title":"FEMS Microbiol Rev"},{"issue":"10","key":"pone.0339449.ref011","article-title":"The spectrum of erythema migrans in early Lyme disease: can we improve its recognition?","volume":"14","author":"AM Schotthoefer","year":"2022","journal-title":"Cureus"},{"key":"pone.0339449.ref012","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jaut.2014.09.004","article-title":"Lyme disease: a rigorous review of diagnostic criteria and treatment","volume":"57","author":"AT Borchers","year":"2015","journal-title":"J Autoimmun"},{"issue":"1","key":"pone.0339449.ref013","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1468-1331.2009.02862.x","article-title":"EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis","volume":"17","author":"A Mygland","year":"2010","journal-title":"Eur J Neurol"},{"issue":"1","key":"pone.0339449.ref014","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2174\/1874372201610010044","article-title":"Nervous System Involvement in Lyme Borreliosis","volume":"10","author":"K Ogrinc","year":"2016","journal-title":"TODJ"},{"key":"pone.0339449.ref015","article-title":"Lyme borreliosis: diagnosis and management","volume":"369","author":"BJ Kullberg","year":"2020","journal-title":"BMJ"},{"issue":"6","key":"pone.0339449.ref016","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1128\/jcm.32.6.1519-1525.1994","article-title":"Serological follow-up after treatment of patients with erythema migrans and neuroborreliosis","volume":"32","author":"S Hammers-Berggren","year":"1994","journal-title":"J Clin Microbiol"},{"issue":"6","key":"pone.0339449.ref017","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1086\/322669","article-title":"Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme disease","volume":"33","author":"RA Kalish","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"6","key":"pone.0339449.ref018","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2021-007744","article-title":"Global seroprevalence and sociodemographic characteristics of Borrelia burgdorferi sensu lato in human populations: a systematic review and meta-analysis","volume":"7","author":"Y Dong","year":"2022","journal-title":"BMJ Glob Health"},{"issue":"7","key":"pone.0339449.ref019","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.3201\/eid2207.151694","article-title":"Current Guidelines, Common Clinical Pitfalls, and Future Directions for Laboratory Diagnosis of Lyme Disease, United States","volume":"22","author":"A Moore","year":"2016","journal-title":"Emerging Infectious Diseases"},{"issue":"9","key":"pone.0339449.ref020","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America","volume":"43","author":"GP Wormser","year":"2006","journal-title":"Clin Infect Dis"},{"key":"pone.0339449.ref021","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00508-015-0936-y","article-title":"Management approaches for suspected and established Lyme disease used at the Lyme disease diagnostic center","volume":"130","author":"GP Wormser","year":"2018","journal-title":"Wien Klin Wochenschr"},{"key":"pone.0339449.ref022","article-title":"L\u00e4kemedelsbehandling av borreliainfektion \u2013 ny rekommendation","volume":"4","author":"L\u00e4kemedelsverket","year":"2009","journal-title":"Information fr\u00e5n L\u00e4kemedelsverket"},{"key":"pone.0339449.ref023","author":"Smittskyddsinstitutet","year":"2013"},{"issue":"10","key":"pone.0339449.ref024","doi-asserted-by":"crossref","DOI":"10.3390\/biology10101036","article-title":"Borreliae Part 1: Borrelia Lyme Group and Echidna-Reptile Group","volume":"10","author":"G Trevisan","year":"2021","journal-title":"Biology"},{"issue":"2","key":"pone.0339449.ref025","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1099\/ijsem.0.003833","article-title":"Borrelia maritima sp. nov., a novel species of the Borrelia burgdorferi sensu lato complex, occupying a basal position to North American species","volume":"70","author":"G Margos","year":"2020","journal-title":"Int J Syst Evol Microbiol"},{"key":"pone.0339449.ref026","author":"SCB"},{"issue":"5","key":"pone.0339449.ref027","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/apm.12664","article-title":"Significant variations in the seroprevalence of C6 ELISA antibodies in a highly endemic area for Lyme borreliosis: evaluation of age, sex and seasonal differences","volume":"125","author":"M Johansson","year":"2017","journal-title":"APMIS"},{"issue":"10","key":"pone.0339449.ref028","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1007\/s10096-019-03631-x","article-title":"Serological diagnostics of Lyme borreliosis: comparison of assays in twelve clinical laboratories in Northern Europe","volume":"38","author":"M Lager","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"11","key":"pone.0339449.ref029","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1111\/apm.12267","article-title":"Seroprevalence of antibodies to Borrelia burgdorferi sensu lato in healthy adults from western Norway: risk factors and methodological aspects","volume":"122","author":"R Hjetland","year":"2014","journal-title":"APMIS"},{"issue":"7","key":"pone.0339449.ref030","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s10096-007-0329-x","article-title":"Comparison of an automated Borrelia indirect chemiluminescent immunoassay (CLIA) with a VlsE\/C6 ELISA and Immunoblot","volume":"26","author":"K Riesbeck","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"5","key":"pone.0339449.ref031","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1600-0463.2008.00842.x","article-title":"C6-peptide serology as diagnostic tool in neuroborreliosis","volume":"116","author":"I Tjernberg","year":"2008","journal-title":"APMIS"},{"issue":"2","key":"pone.0339449.ref032","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.cmi.2017.08.025","article-title":"To test or not to test? Laboratory support for the diagnosis of Lyme borreliosis: a position paper of ESGBOR, the ESCMID study group for Lyme borreliosis","volume":"24","author":"RB Dessau","year":"2018","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"pone.0339449.ref033","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10096-021-04334-y","article-title":"Lyme arthritis in Western Europe: a multicentre retrospective study","volume":"41","author":"C Corre","year":"2022","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"11","key":"pone.0339449.ref034","article-title":"Lyme arthritis is rare in Eastern Denmark","volume":"68","author":"T M\u00fcller","year":"2021","journal-title":"Dan Med J"},{"issue":"6","key":"pone.0339449.ref035","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.semarthrit.2018.09.007","article-title":"Characteristics and clinical outcomes after treatment of a national cohort of PCR-positive Lyme arthritis","volume":"48","author":"A Grillon","year":"2019","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"pone.0339449.ref036","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1056\/NEJM200107123450201","article-title":"Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite","volume":"345","author":"RB Nadelman","year":"2001","journal-title":"N Engl J Med"},{"issue":"10","key":"pone.0339449.ref037","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1007\/s10096-014-2129-4","article-title":"Borrelia burgdorferi sensu lato serology in the Netherlands: guidelines versus daily practice","volume":"33","author":"J Coumou","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"pone.0339449.ref038","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/1471-2334-10-317","article-title":"Utilization of serology for the diagnosis of suspected Lyme borreliosis in Denmark: survey of patients seen in general practice","volume":"10","author":"RB Dessau","year":"2010","journal-title":"BMC Infect Dis"},{"issue":"6","key":"pone.0339449.ref039","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s10096-020-04093-2","article-title":"Serodiagnosis of Lyme borreliosis-is IgM in serum more harmful than helpful?","volume":"40","author":"H Hillerdal","year":"2021","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"pone.0339449.ref040","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-1-0716-3561-2_9","article-title":"Identification of Unambiguous Borrelia Peptides in Human Urine Using Affinity Capture and Mass Spectrometry","volume":"2742","author":"R Cornero","year":"2024","journal-title":"Methods Mol Biol"},{"key":"pone.0339449.ref041","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/978-1-0716-3561-2_8","article-title":"Use of Specific Borrelia Phages as a New Strategy for Improved Diagnostic Tests","volume":"2742","author":"J Shan","year":"2024","journal-title":"Methods Mol Biol"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0339449","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T18:25:23Z","timestamp":1766773523000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0339449"}},"subtitle":[],"editor":[{"given":"Pablo","family":"Colunga-Salas","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,12,26]]},"references-count":41,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0339449","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,26]]}}}